tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

IDXXIdexx Laboratories

Health care · Diagnostics · Nasdaq
Compare with peers → Embed
Planned sales, announced before they happen

0 trading plans running, 14 Form 144 notices for $66.1M

10-Q, 10-K and Form 144
Plans running now
0
none adopted and not yet ended or expired
Plans adoptedList ↓
2
reported since May 2, 2023
Form 144 noticesList ↓
14
$66.1M the sellers expected to sell

What IDXX's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Trading plans

Plans adopted or ended

XBRL, 10-Q and 10-K
InsiderWhatDateSharesRuns toReported in
Jonathan W. Ayers
independent director
Adopted 10b5-1 plan Aug 29, 2024 up to 95,540 Feb 11, 2025 10-Q Oct 31, 2024
What the company wrote
On August 29, 2024, Jonathan W. Ayers, one of our independent directors, entered into a Rule 10b5-1 trading arrangement (the “plan’”) intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. The plan provides for the sale during the duration of the plan and subject to certain price limits, of up to 95,540 shares of common stock underlying a non-qualified stock option equity award granted to Mr. Ayers on February 14, 2015. The plan will expire on February 11, 2025, subject to early termination in accordance with the terms of the plan.
Jonathan W. Ayers
independent director
Adopted plan – not stated – 10-K Feb 21, 2025
What the company wrote
Jonathan W. Ayers resigned as an independent director of the Company on November 8, 2024. As previously reported, Mr. Ayers entered into a Rule 10b5-1 trading arrangement (the “plan”) on August 29, 2024. Mr. Ayers terminated the plan effective November 25, 2024, and no trades were executed under the plan.

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 2, 2023.

Form 144

Notices of planned sales

Form 144 XML, SEC
FiledSellerSharesValueShares came from10b5-1 planForm 4 sales after
Nov 5, 2026 JUNIUS DANIEL M
Director
1,200 $840K Open Market Purchase none given none found
Nov 4, 2026 JUNIUS DANIEL M
Director
500 $346K Open Market Purchase none given 1,200 shares from Nov 4, 2026
Nov 4, 2026 JONATHAN J MAZELSKY
Officer, Director
25,140 $17.7M Stock Option Exercise none given 25,140 shares from Nov 4, 2026
Nov 4, 2026 SHARON E UNDERBERG
Officer
8,906 $6.1M Stock Option Exercise none given 8,906 shares from Nov 4, 2026
Nov 4, 2026 MICHAEL J LANE
Officer
3,979 $2.7M Employee Stock Purchase Plan; Exercised Shares; Restricted Stock none given 3,979 shares from Nov 4, 2026
Sep 4, 2026 LAWRENCE D KINGSLEY
Director
2,203 $1.2M Stock Option Exercise none given 2,203 shares from Sep 4, 2026
May 20, 2026 Margaret Anne Szostak
Director
1,344 $744K Acquired as compensation -- Restricted Stock Units none given none found
Mar 3, 2026 NIMRATA K HUNT
Officer
1,758 $1.1M Exercised Shares none given none found
Feb 26, 2026 JONATHAN J MAZELSKY
Officer, Director
23,326 $15.3M Stock Option Exercise none given none found
Feb 25, 2026 NIMRATA K HUNT
Officer
2,693 $1.8M Exercised Shares none given none found
Feb 17, 2026 SOPHIE V VANDEBROEK
Director
1,464 $920K Restricted Stock; Stock Option Exercise none given none found
Feb 17, 2026 MICHAEL G ERICKSON
Officer
5,371 $3.4M Stock Option Exercise none given none found
Feb 10, 2026 GEORGE FENNELL
Officer
11,345 $7.3M Stock Option Exercise none given none found
Nov 7, 2025 NIMRATA K HUNT
Officer
9,425 $6.6M Stock Option Exercise none given none found
Show the other 6 notices

From the Form 144 XML filed with the SEC, since Nov 7, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Next Owners →